Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Evaluation of Biological Modifiers
Berd, David
Fox Chase Cancer Center, Philadelphia, PA, United States
Search 18 grants from David Berd
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Clinical Hematology Research Career Development Program (K12) at Hopkins
MOMENT (Monitoring for Outpatient Medication Effects and New Toxicities) in TIME
""""""""TRY-IT"""""""" Translating Research to Youth through Information Technology
Activation Gating in Human Heart Na+ Channels
Application of Monoclonal Antibodies to the Study of Oncogene Products
Recently added grants:
Mechanisms that Coordinate Cellular Movements for Epithelial Migration
Functional Roles of Nascent RNA Structure in Regulating and Coordinating Gene Expression
Molecular and Cellular Research to Advance Child Health
Extended Development of the CIPRES Science Gateway, a Resource for Biological Research.
Hired Latino Youth Farmworkers: Work Organization, Safety, Hazards, and Health
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007432-001005
Application #
3608441
Study Section
Project Start
1983-09-30
Project End
Budget Start
1985-08-01
Budget End
1986-01-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Related projects
NIH 1986
N01 CM
Clinical Evaluation of Biological Modifiers
Berd, David / Fox Chase Cancer Center
NIH 1985
N01 CM
Clinical Evaluation of Biological Modifiers
Berd, David / Fox Chase Cancer Center
Publications
Berd, D; Mastrangelo, M J
(1987)
Depletion of suppressor-cytotoxic T-lymphocytes by administration of a murine monoclonal antibody.
Cancer Res 47:2727-32
Comments
Be the first to comment on this grant